Literature DB >> 8776359

Patterns of matrix metalloproteinase and TIMP-1 expression in chronic and normally healing human cutaneous wounds.

M Vaalamo1, M Weckroth, P Puolakkainen, J Kere, P Saarinen, J Lauharanta, U K Saarialho-Kere.   

Abstract

The present study was carried out to characterize the patterns of expression of matrix metalloproteinases or their tissue inhibitor (TIMP-1) in normally healing, acute vs. chronic, skin wounds. In situ hybridization was performed to localize collagenase, stromelysin-1, stromelysin-2, matrilysin, urokinase plasminogen activator (uPA) and TIMP-1 mRNAs in 14 chronic venous ulcers and 10 normally healing wounds, representing different time points after wounding. Surgical wounds, made in piglets harvested at several time points, were studied as controls. Collagenase, stromelysin-1 and -2, as well as uPa, were expressed in keratinocytes in both acute and chronic wounds, while epithelial TIMP-1 mRNA was not detected in any chronic wound biopsies studied. However, TIMP-1 was expressed at the epithelial edges of both acute human and pig wounds. Our results suggest that the balance between metalloenzymes and their inhibitor TIMP-1, is disturbed, in poorly healing wounds.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8776359

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  38 in total

Review 1.  Matrix metalloproteinase biology applied to vitreoretinal disorders.

Authors:  C S Sethi; T A Bailey; P J Luthert; N H Chong
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

Review 2.  Collagenase and surgical disease.

Authors:  Timothy R Donahue; Jonathan R Hiatt; Ronald W Busuttil
Journal:  Hernia       Date:  2006-12       Impact factor: 4.739

3.  siRNA knockdown of tissue inhibitor of metalloproteinase-1 in keloid fibroblasts leads to degradation of collagen type I.

Authors:  Masayo Aoki; Koichi Miyake; Rei Ogawa; Teruyuki Dohi; Satoshi Akaishi; Hiko Hyakusoku; Takashi Shimada
Journal:  J Invest Dermatol       Date:  2013-09-16       Impact factor: 8.551

4.  In vitro and in vivo studies on matrix metalloproteinases interacting with small intestine submucosa wound matrix.

Authors:  Lei Shi; Sarah Ramsay; Ryan Ermis; Dennis Carson
Journal:  Int Wound J       Date:  2011-08-31       Impact factor: 3.315

5.  Bacterial phospholipase C upregulates matrix metalloproteinase expression by cultured epithelial cells.

Authors:  J D Firth; E E Putnins; H Larjava; V J Uitto
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

6.  Upregulation of matrix metalloproteinases in a model of T cell mediated tissue injury in the gut: analysis by gene array and in situ hybridisation.

Authors:  M T Salmela; T T MacDonald; D Black; B Irvine; T Zhuma; U Saarialho-Kere; S L F Pender
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

7.  Matrix metalloproteinase-9 delays wound healing in a murine wound model.

Authors:  Matthew J Reiss; Yan-Ping Han; Edwin Garcia; Mytien Goldberg; Hong Yu; Warren L Garner
Journal:  Surgery       Date:  2009-12-11       Impact factor: 3.982

8.  Fibronectin fragmentation is a feature of periodontal disease sites and diabetic foot and leg wounds and modifies cell behavior.

Authors:  Corey M Stanley; Yao Wang; Sanjay Pal; Robert J Klebe; Lawrence B Harkless; Xiaoping Xu; Zhihua Chen; Bjorn Steffensen
Journal:  J Periodontol       Date:  2008-05       Impact factor: 6.993

9.  Tissue inhibitor of metalloproteinase-1 moderates airway re-epithelialization by regulating matrilysin activity.

Authors:  Peter Chen; John K McGuire; Robert C Hackman; Kyoung-Hee Kim; Roy A Black; Kurt Poindexter; Wei Yan; Phillip Liu; Ann J Chen; William C Parks; David K Madtes
Journal:  Am J Pathol       Date:  2008-04-01       Impact factor: 4.307

10.  Increased matrix metalloproteinase-9 predicts poor wound healing in diabetic foot ulcers.

Authors:  Yu Liu; Danqing Min; Thyra Bolton; Vanessa Nubé; Stephen M Twigg; Dennis K Yue; Susan V McLennan
Journal:  Diabetes Care       Date:  2008-10-03       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.